Search

Your search keyword '"Brusamolino, E."' showing total 277 results

Search Constraints

Start Over You searched for: Author "Brusamolino, E." Remove constraint Author: "Brusamolino, E."
277 results on '"Brusamolino, E."'

Search Results

2. CFU-GM Growth from Peripheral Blood Stem Cells (PBSC) Before and After Cryopreservation : Comparison with Bone Marrow Cells

13. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned

17. Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma

18. In vivo purging followed by autotransplant induces long clinical and molecular remission in relapsed/refractory follicular lymphoma patient

19. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study

22. MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study

27. Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial

28. Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi

30. Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis

31. Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity

34. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned

36. Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

37. Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers

41. Risk assessment in myelodysplastic syndromes: Value of clinical, hematologic and bone marrow histologic findings at presentation

42. Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up

43. A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and nontoxic treatment for advanced follicular and mantle cell lymphoma

44. Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients

45. Comparable 3-year outcome following ABVD or BEACOPP first-line chemotherapy, plus pre-planned high-dose salvage, in advanced Hodgkin lymphoma (HL): A randomized trial of the Michelangelo, GITIL and IIL cooperative groups

Catalog

Books, media, physical & digital resources